Prescription eye ointment recalled for temperature storage deviations
McKesson Medical-Surgical recalls Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment (120 tubes) nationwide due to temperature storage deviations during manufacturing.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for manufacturing deviations affecting a prescription ophthalmic medication. Temperature abuse of pharmaceuticals poses a potential risk to product stability and efficacy. No illnesses or injuries have been reported.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment in 3.5 g tubes (NDC 61314-631-36) due to Current Good Manufacturing Practice (cGMP) deviations involving temperature abuse during storage and distribution.
Temperature deviations can affect the stability and efficacy of pharmaceutical products. The medication was manufactured by Sandoz and distributed nationwide in the United States. McKesson Medical-Surgical cannot identify specific lot numbers for individual consignees; affected customers received separate notification letters with distribution dates and relevant shipment timeframes.
Healthcare providers and patients with this medication should contact their pharmacist or healthcare provider for guidance. Patients should not use the product if there is concern it was exposed to improper temperatures. Return the medication to your pharmacy for proper disposal.
This is an FDA Class II recall (D-1102-2022). For additional information, consult your healthcare provider or visit the FDA's drug recalls page at https://www.fda.gov/drugs/drug-safety-and-availability/drug-recalls.
The recalled product
- Product
- NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE)
- Brand
- NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Ophthalmic
- Affected units
- 120
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same brand · NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
- LowSandoz Recalls Neomycin and Polymyxin B Ophthalmic Suspension for Labeling Error
FDA (Drugs) · 2019-11-06
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18